Cochlear

Cochlear

Helps transform the way people understand and treat hearing loss.

Launch date
Employees
Market cap
€11.2b
Enterprise valuation
€11.0b (Public information from Sep 2024)
Sydney New South Wales (HQ & founding location)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
AUD2021202220232024202520262027
Revenues1.5b1.6b1.9b2.2b2.5b2.7b2.9b
% growth13 %10 %17 %15 %10 %9 %9 %
EBITDA457m475m487m579m643m713m806m
% EBITDA margin31 %29 %25 %26 %26 %27 %28 %
Profit327m289m301m357m422m469m532m
% profit margin22 %18 %16 %16 %17 %18 %18 %
EV / revenue10.7x7.5x7.6x9.7x7.8x7.2x6.5x
EV / EBITDA35.0x26.2x30.2x37.6x29.9x26.9x23.7x
R&D budget195m211m245m277m---
R&D % of revenue13 %13 %13 %12 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
Total Funding-

Recent News about Cochlear

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Cochlear

Edit
Nyxoah
exited
Oticon Medical
ACQUISITION by Cochlear Apr 2022